FDA
approval
· 2018-04-11
FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Original Application (Solco Healthcare LLC)
Summary
FDA approved a generic fixed-dose combination of candesartan cilexetil and hydrochlorothiazide for hypertension under an Original Application.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE)